Cancer SurvivorshipNCT07712133
Improving Radon Education and Awareness in Cancer Patients and Their Extended Community
A study testing Educational Presentation in people with Cancer Survivorship, run by University of Utah at 1 site in United States.
Trial summary
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer Survivorship
- What is being tested?
- Educational Presentation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2026to Jun 2028
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult age 18 or older
- Patient of HCI or friend/family or caregiver of patient of HCI (eligible if living in same home or different homes)
- Resident of Utah, Wyoming, Idaho, Montana, or Nevada
- Able to provide consent
Who cannot join
- Below age 18
- Resident of a state other than Utah, Wyoming, Idaho, Montana, or Nevada
- Not able to provide consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112
Kathryn Weaver, 801-646-4458, kathryn.weaver@hci.utah.edu
Judy Ou, PhD
About this study
Clinical appointments are an opportunity to provide cancer survivors (defined as patients and survivors) and people in their communities (e.g. caregivers, family members, friends) with education about radon and radon testing. This is a pilot study to develop and evaluate the impact of a clinic-based intervention that educates cancer survivors and their caregivers/families about radon and radon testing. This study will enroll survivors, caregivers, and interested family members or friends in this intervention because they are important decision-makers with respect to the survivors' cancer care and well-being. This intervention would occur in clinics that treat lung cancer as well as clinics that treat cancers for which radon is being investigated as a contributor to their etiology (e.g. breast, skin melanoma, gastrointestinal).
- Conditions
- Cancer Survivorship
- Being tested
- Educational Presentation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational PresentationBehavioural
A study staff member will deliver a short educational intervention about radon via PowerPoint with a standardized script to participants.
The intervention can be delivered online or in person. If in person, the caregiver and patient will listen to the presentation given by the study team member. If done online, the presentation will be conducted by a study team member using secured video conference software (e.g. Zoom, Teams).
| Study group | Role | What they receive |
|---|---|---|
| Radon Educational Session | Other | One short, educational intervention presentation will be given. The educational component is estimated to take 15-30 minutes, depending on how many questions people have. Receives: Behavioral: Educational Presentation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Radon Knowledge
To compare participants' pre- and post-intervention knowledge about radon based on demographics and estimated residential radon levels. Radon knowledge will be assessed using a questionnaire with total scores ranging from 0 to 5, where higher scores indicate greater radon knowledge and lower scores indicate less radon knowledge.
Measured: up to 1 day
Secondary outcomes (1)
Proportion of Participants that Test for Radon
To identify the proportion of participants that test for radon after the intervention according to demographics, estimated residential radon levels, and offered financial incentive.
Measured: up to 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2026
- Study startSep 2026 (estimated)
- Primary completionJun 2028 (estimated)
- Study completionJun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer SurvivorshipStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Collaborators
- Huntsman Cancer Institute
- Responsible party
- Sponsor
- Investigators
- Judy Ou, PhD, Principal investigator, Huntsman Cancer Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07712133
- Sponsor's protocol ID
- 192718
- Status last verified
- Jul 2026
- First submitted
- 7 Jul 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No